Innovating Works

Cellix Ltd.

Desconocido
TAPAS: TArgeting Platelet Adhesion receptors in thrombosiS CELLIX LIMITED participó en un H2020: H2020-MSCA-ITN-2017 TAPAS will position Europe at the forefront of innovative research to prevent thrombosis and thromboinflammation, and will train a uniquely-...
2017-08-17 - 2022-06-30 | Financiado
INISH MINI-BAR: Inish Mini for On Site Rapid Detection of Bacteria in Beer Directly from the Tap CELLIX LIMITED tramitó un H2020: H2020-SMEInst-2016-2017 Cellix's goal is to launch the INISH MINI-BAR; a new low-cost, portable, rapid diagnostic device for fast and reliable detection of bacteria...
2016-12-22 - 2018-12-31 | Financiado
SNIFFPHONE: Smart Phone for Disease Detection from Exhaled Breath CELLIX LIMITED participó en un H2020: H2020-ICT-2014 Screening for early detection of a disease is required to reveal groups of individuals from the general population in whom the likelihood of...
2014-12-18 - 2019-02-14 | Financiado
HYSENS: Hybrid Molecule Nanocrystal Assemblies for Photonic and Electronic Sensing Applications CELLIX LIMITED participó en un FP7: Functional organic molecules and metal and semiconductor nanocrystals represent attractive building blocks due to their composition-, size-...
Financiado
NAMDIATREAM: NANOTECHNOLOGICAL TOOLKITS FOR MULTI MODAL DISEASE DIAGNOSTICS AND TREATMENT MONITORING CELLIX LIMITED participó en un FP7: NAMDIATREAM will develop a cutting edge nanotechnology-based toolkit for multi-modal detection of biomarkers of most common cancer types and...
Financiado
LiPhos: Living Photonics Monitoring light propagation through cells CELLIX LIMITED participó en un FP7: LIPHOS is focused on the development of completely innovative biophotonic diagnosis tools, which are for the first time implemented using ce...
Financiado
TARGET-MELANOMA: Molecular Dissection of Melanoma Progression An integrated Pan European Approach Transformed melanocytes use several strategies to enable their progression to advanced melanoma and metastasis, including genetic and epigen...
Financiado
DIMID: Development of an Innovative Microfluidic Impedance based Device for multi parametric cell analysis CELLIX LIMITED participó en un FP7: "Cell analysis has become an important technique and represents a fast growing market for a wealth of applications in the fields of life sci...
Financiado
DIMIDplus: Commercialization of an Innovative Microfluidic Impedance based Device for multi parametric cell ana... CELLIX LIMITED participó en un FP7: This DIMIDplus Demonstration Action is a direct follow-on of the DIMID (286692, FP7-SME-2011) project. The DIMID project is successful, on t...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.